Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.

SHREVEPORT, La. — When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been easy in the years since he was diagnosed with the human ...

Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch ...

Comparison of mortality rates in the United States population suffering from Hodgkin's versus non-Hodgkin's lymphoma: A CDC Wonder database study from 1999-2020. This is an ASCO Meeting Abstract from ...

Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025. Total revenues comprise product sales and royalty, contract and other revenues. While ...

After an ex-girlfriend accused Robert Smith of a felony called "intentional exposure to HIV," he accepted a plea deal to spend six months in prison without realizing the conviction would also land him ...

Concern is growing that the scramble for scarce supplies of monkeypox vaccines could see some nations and high-risk groups ...